Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1805.85
(0.31%)
INR 1805.85
(0.31%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 154.18 Billion INR | -34.03% |
| 2022 | 233.73 Billion INR | 17.01% |
| 2021 | 199.74 Billion INR | 18.05% |
| 2020 | 169.21 Billion INR | 0.02% |
| 2019 | 169.18 Billion INR | 14.91% |
| 2018 | 147.22 Billion INR | 11.94% |
| 2017 | 131.52 Billion INR | 9.4% |
| 2016 | 120.22 Billion INR | -4.96% |
| 2015 | 126.49 Billion INR | 0.28% |
| 2014 | 126.14 Billion INR | 114.48% |
| 2013 | 58.81 Billion INR | 43.6% |
| 2012 | 40.95 Billion INR | 34.34% |
| 2011 | 30.48 Billion INR | 34.1% |
| 2010 | 22.73 Billion INR | 75.42% |
| 2009 | 12.96 Billion INR | -11.68% |
| 2008 | 14.67 Billion INR | 41.79% |
| 2007 | 10.34 Billion INR | 42.68% |
| 2006 | 7.25 Billion INR | 31.47% |
| 2005 | 5.51 Billion INR | 24.77% |
| 2004 | 4.42 Billion INR | 21.21% |
| 2003 | 3.64 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 73.85 Billion INR | 11.49% |
| 2024 Q1 | 38.64 Billion INR | -8.24% |
| 2023 Q1 | 63.48 Billion INR | 0.49% |
| 2023 Q4 | 42.11 Billion INR | -37.04% |
| 2023 Q3 | 66.89 Billion INR | 0.82% |
| 2023 Q2 | 66.35 Billion INR | 4.52% |
| 2023 FY | 154.18 Billion INR | -34.03% |
| 2022 Q1 | 55.93 Billion INR | 60.24% |
| 2022 Q4 | 63.17 Billion INR | 6.19% |
| 2022 FY | 233.73 Billion INR | 17.01% |
| 2022 Q2 | 55.13 Billion INR | -1.43% |
| 2022 Q3 | 59.49 Billion INR | 7.92% |
| 2021 Q4 | 34.9 Billion INR | -31.7% |
| 2021 FY | 199.74 Billion INR | 18.05% |
| 2021 Q1 | 47.82 Billion INR | 38.23% |
| 2021 Q3 | 51.1 Billion INR | 5.17% |
| 2021 Q2 | 48.58 Billion INR | 1.61% |
| 2020 Q1 | 42.47 Billion INR | 18.37% |
| 2020 Q2 | 45.17 Billion INR | 6.35% |
| 2020 Q3 | 46.72 Billion INR | 3.44% |
| 2020 Q4 | 34.59 Billion INR | -25.97% |
| 2020 FY | 169.21 Billion INR | 0.02% |
| 2019 Q2 | 43.73 Billion INR | 0.99% |
| 2019 Q1 | 43.3 Billion INR | 39.57% |
| 2019 Q3 | 46.26 Billion INR | 5.78% |
| 2019 Q4 | 35.88 Billion INR | -22.43% |
| 2019 FY | 169.18 Billion INR | 14.91% |
| 2018 Q2 | 38.08 Billion INR | 1.91% |
| 2018 FY | 147.22 Billion INR | 11.94% |
| 2018 Q1 | 37.37 Billion INR | 0.66% |
| 2018 Q4 | 31.02 Billion INR | -23.13% |
| 2018 Q3 | 40.36 Billion INR | 5.98% |
| 2017 Q3 | 33.84 Billion INR | -8.42% |
| 2017 Q2 | 36.95 Billion INR | -1.2% |
| 2017 FY | 131.52 Billion INR | 9.4% |
| 2017 Q1 | 37.4 Billion INR | 9.34% |
| 2017 Q4 | 37.12 Billion INR | 9.7% |
| 2016 Q3 | 32.88 Billion INR | 7.97% |
| 2016 Q1 | 35.54 Billion INR | -11.65% |
| 2016 Q4 | 34.2 Billion INR | 4.03% |
| 2016 Q2 | 30.45 Billion INR | -14.33% |
| 2016 FY | 120.22 Billion INR | -4.96% |
| 2015 FY | 126.49 Billion INR | 0.28% |
| 2015 Q1 | 35.42 Billion INR | -15.96% |
| 2015 Q4 | 40.23 Billion INR | 18.52% |
| 2015 Q3 | 33.94 Billion INR | -9.74% |
| 2015 Q2 | 37.61 Billion INR | 6.17% |
| 2014 Q4 | 42.15 Billion INR | 28.38% |
| 2014 Q3 | 32.83 Billion INR | -4.13% |
| 2014 FY | 126.14 Billion INR | 114.48% |
| 2014 Q1 | 29.93 Billion INR | 182.98% |
| 2014 Q2 | 34.25 Billion INR | 14.42% |
| 2013 Q1 | 15.24 Billion INR | 72.0% |
| 2013 FY | 58.81 Billion INR | 43.6% |
| 2013 Q4 | 10.57 Billion INR | -35.26% |
| 2013 Q3 | 16.34 Billion INR | -1.79% |
| 2013 Q2 | 16.63 Billion INR | 9.17% |
| 2012 Q3 | 11.16 Billion INR | 3.04% |
| 2012 Q2 | 10.83 Billion INR | 8.99% |
| 2012 Q1 | 9.93 Billion INR | 63.24% |
| 2012 FY | 40.95 Billion INR | 34.34% |
| 2012 Q4 | 8.86 Billion INR | -20.61% |
| 2011 Q4 | 6.08 Billion INR | -30.87% |
| 2011 Q3 | 8.8 Billion INR | 8.0% |
| 2011 FY | 30.48 Billion INR | 34.1% |
| 2011 Q2 | 8.15 Billion INR | 9.54% |
| 2011 Q1 | 7.44 Billion INR | 0.0% |
| 2010 FY | 22.73 Billion INR | 75.42% |
| 2009 FY | 12.96 Billion INR | -11.68% |
| 2008 FY | 14.67 Billion INR | 41.79% |
| 2007 FY | 10.34 Billion INR | 42.68% |
| 2006 FY | 7.25 Billion INR | 31.47% |
| 2005 FY | 5.51 Billion INR | 24.77% |
| 2004 FY | 4.42 Billion INR | 21.21% |
| 2003 FY | 3.64 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Ajanta Pharma Limited | 30.46 Billion INR | -406.133% |
| Amrutanjan Health Care Limited | 1.09 Billion INR | -13929.434% |
| Sigachi Industries Limited | 579.88 Million INR | -26488.249% |
| Bal Pharma Limited | 389.89 Million INR | -39444.949% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -7158.401% |
| Medico Remedies Limited | 161.84 Million INR | -95165.688% |
| Lasa Supergenerics Limited | 291.17 Million INR | -52851.775% |
| Venus Remedies Limited | 1.91 Billion INR | -7945.874% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -4911.109% |
| Alpa Laboratories Limited | 156.14 Million INR | -98641.442% |
| Nectar Lifesciences Limited | 625.55 Million INR | -24547.398% |
| Shilpa Medicare Limited | 2.18 Billion INR | -6970.649% |
| Aarti Drugs Limited | 1.16 Billion INR | -13106.387% |
| Lupin Limited | 95.67 Billion INR | -61.154% |
| Aurobindo Pharma Limited | 39.23 Billion INR | -292.968% |
| Zydus Lifesciences Limited | 43.17 Billion INR | -257.117% |
| Windlas Biotech Limited | 1 Billion INR | -15218.457% |
| Suven Life Sciences Limited | 109.75 Million INR | -140384.556% |
| Eris Lifesciences Limited | 4.94 Billion INR | -3019.233% |
| Valiant Laboratories Limited | 36.28 Million INR | -424772.0% |
| J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | -1731.773% |
| Solara Active Pharma Sciences Limited | 4.57 Billion INR | -3266.635% |
| Ipca Laboratories Limited | 13.91 Billion INR | -1008.034% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -10763.825% |
| Achyut Healthcare Limited | 1.6 Million INR | -9582361.156% |
| Bajaj HealthCare Limited | 985.34 Million INR | -15547.494% |
| RPG Life Sciences Limited | 1.63 Billion INR | -9327.197% |
| Mankind Pharma Limited | 23.15 Billion INR | -565.933% |
| Laurus Labs Limited | 3.01 Billion INR | -5020.958% |
| Piramal Pharma Limited | 19.91 Billion INR | -674.238% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -16260.565% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -619.732% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -871.548% |
| Glenmark Pharmaceuticals Limited | 67.56 Billion INR | -128.201% |
| Unichem Laboratories Limited | 6.72 Billion INR | -2192.37% |
| Sequent Scientific Limited | 2.9 Billion INR | -5213.298% |
| Novartis India Limited | 470.1 Million INR | -32697.66% |
| Wanbury Limited | 1.16 Billion INR | -13180.921% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -10891.09% |
| Wockhardt Limited | 6.4 Billion INR | -2309.091% |
| Themis Medicare Limited | 782.85 Million INR | -19594.809% |
| Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -19835.325% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -966.707% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -1224.507% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | -60.81% |
| Divi's Laboratories Limited | 14.17 Billion INR | -988.086% |
| NATCO Pharma Limited | 10.05 Billion INR | -1432.927% |
| Gufic Biosciences Limited | 1.07 Billion INR | -14206.414% |
| IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | -13931.835% |
| Ind-Swift Limited | 946.56 Million INR | -16188.525% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -5047.286% |
| FDC Limited | 5.34 Billion INR | -2782.695% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -333944.978% |
| Granules India Limited | 7.18 Billion INR | -2046.67% |
| Medicamen Biotech Limited | 335.16 Million INR | -45901.486% |
| Alkem Laboratories Limited | 32.83 Billion INR | -369.565% |
| AstraZeneca Pharma India Limited | 2.6 Billion INR | -5829.157% |
| Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -951070.037% |
| Brooks Laboratories Limited | 51.18 Million INR | -301154.005% |
| Megasoft Limited | 49.52 Million INR | -311202.3% |
| ZIM Laboratories Limited | 1.01 Billion INR | -15119.444% |
| Strides Pharma Science Limited | 9.16 Billion INR | -1582.785% |
| Neuland Laboratories Limited | 2.92 Billion INR | -5162.634% |
| Morepen Laboratories Limited | 1.98 Billion INR | -7657.77% |
| Hikal Limited | 2.48 Billion INR | -6101.155% |
| Indoco Remedies Limited | 4.74 Billion INR | -3146.772% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -4915.021% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -37284.022% |
| Mangalam Drugs & Organics Limited | 676.14 Million INR | -22703.0% |
| Hester Biosciences Limited | 908.84 Million INR | -16864.68% |